IL-4对IL-2诱导LAK细胞和激活肿瘤浸润性淋巴细胞抗肿瘤活性的影响

被引:1
作者
曹雪涛
叶天星
杨嗣坤
徐志工
孔宪涛
机构
[1] 第二军医大学免疫学教研室上海
关键词
白细胞介素4; 白细胞介素2; 淋巴因子激活的杀伤细胞; 肿瘤浸润性淋巴细胞; 抗肿瘤免疫;
D O I
暂无
中图分类号
R730.51 [免疫疗法];
学科分类号
摘要
为了提高肿瘤过继免疫疗法的抗肿瘤效果, 本研究试图应用白细胞介素4 (IL-4)提高具有显著抗肿瘤作用的免疫效应细胞(LAK和TIL)的体外杀伤活性, 结果表明, IL-4单独并不能诱导出LAK活性, IL-4对LAK细胞的抗肿瘤活性呈剂量依赖性地抑制作用, 抗IL- 4单抗(11B11)能完全阻断IL-4对LAK活性的抑制作用。但IL-4能够进一步增强IL-2激活的TIL的抗肿瘤活性, 这对于肿瘤的免疫治疗有很大的实用价值。文中对IL-4的作用机理进行了探讨。
引用
收藏
相关论文
共 15 条
[1]   MURINE INTERLEUKIN-4 DISPLAYS POTENT ANTI-TUMOR ACTIVITY INVIVO [J].
TEPPER, RI ;
PATTENGALE, PK ;
LEDER, P .
CELL, 1989, 57 (03) :503-512
[2]  
IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion; cytotoxicity; and phenotype of lymphokine-activated killer effectors..[J].Mulé J J;Krosnick J A;Rosenberg S A.Journal of immunology (Baltimore; Md. : 1950).1989, 2
[3]  
The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation..[J].Nagler A;Lanier L L;Phillips J H.Journal of immunology (Baltimore; Md. : 1950).1988, 7
[4]   A NEW APPROACH TO GENERATING ANTITUMOR EFFECTORS FOR ADOPTIVE IMMUNOTHERAPY USING HUMAN ADHERENT LYMPHOKINE-ACTIVATED KILLER CELLS [J].
MELDER, RJ ;
WHITESIDE, TL ;
VUJANOVIC, NL ;
HISERODT, JC ;
HERBERMAN, RB .
CANCER RESEARCH, 1988, 48 (12) :3461-3469
[5]   THE IL-2 RECEPTOR BETA-CHAIN (P70) - ROLE IN MEDIATING SIGNALS FOR LAK, NK, AND PROLIFERATIVE ACTIVITIES [J].
SIEGEL, JP ;
SHARON, M ;
SMITH, PL ;
LEONARD, WJ .
SCIENCE, 1987, 238 (4823) :75-78
[6]   REGULATION OF CYTOLYTIC LYMPHOCYTE-T GENERATION BY B-CELL STIMULATORY FACTOR [J].
WIDMER, MB ;
GRABSTEIN, KH .
NATURE, 1987, 326 (6115) :795-798
[7]  
Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody.[J].J. R. F. Corvalan;W. Smith;V. A. Gore;D. R. Brandon;P. J. Ryde.Cancer Immunology Immunotherapy.1987, 2
[8]   A NEW APPROACH TO THE ADOPTIVE IMMUNOTHERAPY OF CANCER WITH TUMOR-INFILTRATING LYMPHOCYTES [J].
ROSENBERG, SA ;
SPIESS, P ;
LAFRENIERE, R .
SCIENCE, 1986, 233 (4770) :1318-1321
[9]  
The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cel.[J].Mulé J J;Yang J;Shu S;Rosenberg S A.Journal of immunology (Baltimore; Md. : 1950).1986, 10
[10]  
Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects..[J].Ortaldo J R;Mason A T;Gerard J P;Henderson L E;Farrar W;Hopkins R F;Herberman R B;Rabin H.Journal of immunology (Baltimore; Md. : 1950).1984, 2